Search in:

Advanced search

Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Increase in spleen volume as a predictor of oxaliplatin toxicity

Alissar El Chediak1 Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut-Medical Center, Beirut, Lebanon

Ali A Haydar2 Department of Diagnostic Radiology, American University of Beirut-Medical Center, Beirut, Lebanon

Ayman Hakim1 Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut-Medical Center, Beirut, Lebanon

Sarah Abdel Massih1 Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut-Medical Center, Beirut, Lebanon

Lara Hilal3 Department of Radiation Oncology, American University of Beirut-Medical Center, Beirut, Lebanon

Deborah Mukherji1 Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut-Medical Center, Beirut, Lebanon

Sally Temraz1 Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut-Medical Center, Beirut, Lebanon

Ali Shamseddine1 Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut-Medical Center, Beirut, LebanonCorrespondence[email protected]

show all

Pages 653-657 | Published online: 11 Apr 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MissetJLOxaliplatin in practiceBr J Cancer199877Suppl 4479647612
PubMed Web of Science ®Google Scholar
OvermanMJMaruDMCharnsangavejCOxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injuryJ Clin Oncol201028152549255520406923
PubMed Web of Science ®Google Scholar
ImaiKEmiYIyamaKISplenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndromeEur J Surg Oncol201440555956624388740
PubMed Web of Science ®Google Scholar
SimpsonDDunnCCurranMGoaKLOxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancerDrugs200363192127215612962525
PubMed Web of Science ®Google Scholar
Diaz-RubioEEvansTRTabemeroJCapecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumorsAnn Oncol200213455856512056706
PubMed Web of Science ®Google Scholar
HoffPMSaadEDCostaFLiterature review and practical aspects on the management of oxaliplatin-associated toxicityClin Colorectal Cancer20121129310022154408
PubMed Web of Science ®Google Scholar
JardimDLRodriguesCANovisYARochaVGHoffPMOxaliplatin-related thrombocytopeniaAnn Oncol20122381937194222534771
PubMed Web of Science ®Google Scholar
Rubbia-BrandtLAudardVSartorettiPSevere hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerAnn Oncol200415346046614998849
PubMed Web of Science ®Google Scholar
TismanGMacDonaldDShindellNOxaliplatin toxicity masquerading as recurrent colon cancerJ Clin Oncol200422153202320415284280
PubMed Web of Science ®Google Scholar
De OdoricoISpauldingKAPretoriusDHLev-ToaffASBaileyTBNelsonTRNormal splenic volumes estimated using three-dimensional ultrasonographyJ Ultrasound Med199918323123610082358
PubMed Web of Science ®Google Scholar
AsgharAAgrawalDYunusSMSharmaPKZaidiSHSinhaAStandard splenic volume estimation in North Indian adult population: using 3D reconstruction of abdominal CT scan imagesAnat Res Int2011201170732522567297
PubMedGoogle Scholar
MusaAFAbdoDAMZidanMMAAliWMKhojalySNEstimation of splenic volume in Sudanese adult population using abdominal computed tomography scanInt J Med Imaging20175114
Google Scholar
PrassopoulosPDaskalogiannakiMRaissakiMHatjidakisAGourtsoyiannisNDetermination of normal splenic volume on computed tomography in relation to age, gender and body habitusEur Radiol199772246248
PubMed Web of Science ®Google Scholar
HarrisAKamishimaTHaoHYSplenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parametersEur J Radiol2010751e97e101
Web of Science ®Google Scholar
BensonAB3rdVenookAPCederquistLChanEChenYJCooperHSColon Cancer, Version 1, 2017, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network: JNCCN201715337039828275037
PubMed Web of Science ®Google Scholar
MehtaNNRavikumarRColdhamCAEffect of preoperative chemotherapy on liver resection for colorectal liver metastasesEur J Surg Oncol200834778278618160247
PubMed Web of Science ®Google Scholar
NakanoHOussoultzoglouERossoESinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapyAnn Surg2008247111812418156931
PubMed Web of Science ®Google Scholar
VautheyJNPawlikTMRiberoDChemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastasesJ Clin Oncol200624132065207216648507
PubMed Web of Science ®Google Scholar
MazonakisMDamilakisJMarisTPrassopoulosPGourtsoyiannisNEstimation of spleen volume using MR imaging and a random marking techniqueEur Radiol200010121899190311305567
PubMed Web of Science ®Google Scholar
AngitapalliRLitwinAMKumarPRAdjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II–III colorectal cancerOncology200976536336819321964
PubMed Web of Science ®Google Scholar
JungEJRyuCGKimGSplenomegaly during oxaliplatin-based chemotherapy for colorectal carcinomaAnticancer Res20123283357336222843915
PubMed Web of Science ®Google Scholar
sanofi-aventisELOXATIN® [prescribing information]Bridgewater Township, NJ201514
Google Scholar
ParkSKimHYKimHChanges in noninvasive liver fibrosis indices and spleen size during chemotherapy: potential markers for oxaliplatin-induced sinusoidal obstruction syndromeMedicine2016952e245426765438
PubMed Web of Science ®Google Scholar
RennCLCarozziVARheePGallopDDorseySGCavalettiGMultimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in miceMol Pain201172921521528
PubMed Web of Science ®Google Scholar
KokotisPSchmelzMKostourosEKarandreasNDimopoulosMAOxaliplatin-induced neuropathy: a long-term clinical and neurophysiologic follow-up studyClin Colorectal Cancer2016153e133e14027038553
PubMed Web of Science ®Google Scholar
PatelKBedossaPCasteraLDiagnosis of liver fibrosis: present and futureSemin Liver Dis201535216618325974902
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Increase in spleen volume as a predictor of oxaliplatin toxicity

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Increase in spleen volume as a predictor of oxaliplatin toxicity

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date